var path='https://www.tickertech.net'; function heading(heading) { document.write('
'+heading+' |
'+ ''+ ' |
'); } function hiLite(imgDocID,imgObjName) { document.images[imgDocID].src = eval(imgObjName + ".src"); } function showStatus(toshow) { window.status = toshow; } function checkChoose() { if (document.choose.ticker.value == "") { alert("Please enter symbols before clicking the go button"); return false; } else return true; } function popJT(url,name){ var xwid = screen.width; xwid = xwid - 10; javaticker = window.open(url,name,'width='+xwid+',height=100,resizable=yes,scrollbars=no,toolbar=no,location=no,directories=no,status=yes,menubar=no'); javaticker.opener.name="opener"; //javaticker.moveTo(0,30); } var allow = 0; var ref = ""+location; if ((ref.indexOf("cryptocurrencieschannel.com") > 0) || (ref.indexOf("cefchannel.com") > 0) || (ref.indexOf("bdcinvestor.com") > 0) || (ref.indexOf("tickertech.com") > 0) || (ref.indexOf("xxxx:") > 0) || (ref.indexOf("javascript:") > 0) || (ref.indexOf("filseclab.com") > 0) || (ref.indexOf("msnscache.com") > 0) || (ref.indexOf("toolbar.google.com") > 0) || (ref.indexOf("etfchannel.com") > 0) || (ref.indexOf("marketnewsvideo.com") > 0) || (ref.indexOf("news.google.com") > 0) || (ref.indexOf("dividendchannel.com") > 0) || (ref.indexOf("www.google.com") > 0) || (ref.indexOf("energystockchannel.com") > 0) || (ref.indexOf("metalschannel.com") > 0) || (ref.indexOf("portfoliochannel.com") > 0) || (ref.indexOf("canadastockchannel.com") > 0) || (ref.indexOf("theonlineinvestor.com") > 0) || (ref.indexOf("investhelp.com") > 0) || (ref.indexOf("preferredstockchannel.com") > 0) || (ref.indexOf("stockoptionschannel.com") > 0) || (ref.indexOf("holdingschannel.com") > 0) || (ref.indexOf("tickertech.net") > 0) || (ref.indexOf("historicalstockprice.com") > 0) || (ref.indexOf("splithistory.com") > 0) || (ref.indexOf("stocksplithistory.com") > 0) || (ref.indexOf("google.c") > 0) || (ref.indexOf("208.71.46.190") > 0) || (ref.indexOf("search.yahoo") > 0) || (ref.indexOf("sharesoutstandinghistory.com") > 0) || (ref.indexOf("marketcaphistory.com") > 0) || (ref.indexOf("ytdreturn.com") > 0) || (ref.indexOf("averageannualreturn.com") > 0) || (ref.indexOf("redinews.com") > 0) || (ref.indexOf("technicalanalysischannel.com") > 0) || (ref.indexOf("stockdma.com") > 0) || (ref.indexOf("stockrsi.com") > 0) || (ref.indexOf("stockmacd.com") > 0) || (ref.indexOf("topdividends.com") > 0) || (ref.indexOf("monthlydividendpayingstocks.com") > 0) || (ref.indexOf("nextearningsdate.com") > 0) || (ref.indexOf("pastearnings.com") > 0) || (ref.indexOf("historicalperatio.com") > 0) || (ref.indexOf("historicalearnings.com") > 0) || (ref.indexOf("webcache.googleusercontent.com") > 0)) { allow = 1; } function ShowTTIPage() { if (allow) { document.write('\n'); } if (allow) { document.write('
\n'); } if (allow) { document.write('4/26 - 8:00 AM \; \; | \n'); } if (allow) { document.write('FDA Approves Biktarvy Label Update With Data for Pregnant Adults With HIV | \n'); } if (allow) { document.write('
4/25 - 4:02 PM \; \; | \n'); } if (allow) { document.write('Gilead Sciences Announces First Quarter 2024 Financial Results | \n'); } if (allow) { document.write('
4/18 - 1:46 PM \; \; | \n'); } if (allow) { document.write('Gilead Sciences Publishes 2023 ESG Impact Report | \n'); } if (allow) { document.write('
4/8 - 4:05 PM \; \; | \n'); } if (allow) { document.write('Gilead Sciences to Release First Quarter 2024 Financial Results on Thursday, April 25, 2024 | \n'); } if (allow) { document.write('
4/2 - 9:21 AM \; \; | \n'); } if (allow) { document.write('Gilead Sciences Champions Equal Pay | \n'); } if (allow) { document.write('
3/28 - 8:30 AM \; \; | \n'); } if (allow) { document.write('FDA Expands Indication for Gilead\'s Vemlidy (Tenofovir Alafenamide) to Treat Chronic HBV Infection in Pediatric Patients as Young as Six | \n'); } if (allow) { document.write('
3/28 - 7:00 AM \; \; | \n'); } if (allow) { document.write('Gilead and Xilio Announce Exclusive License Agreement for Tumor-Activated IL-12 Program | \n'); } if (allow) { document.write('
3/26 - 9:16 AM \; \; | \n'); } if (allow) { document.write('Winn Awards Help Physicians Solve Healthcare Disparities | \n'); } if (allow) { document.write('
3/22 - 9:18 AM \; \; | \n'); } if (allow) { document.write('Gilead Sciences Announces Completion of Acquisition of CymaBay | \n'); } if (allow) { document.write('
3/19 - 9:11 AM \; \; | \n'); } if (allow) { document.write('Gilead Helps Launch T rkiye s First HIV Testing Week | \n'); } if (allow) { document.write('
3/18 - 7:29 PM \; \; | \n'); } if (allow) { document.write('Center for Disease Analysis Foundation Announces First Round of Grantees for the CDAF-Relink Grant | \n'); } if (allow) { document.write('
3/12 - 8:46 AM \; \; | \n'); } if (allow) { document.write('Gilead Science Supports Increasing Diversity in Clinical Trials: 2024 Toward Health Equity Oncology Grant Supports 36 Global Organizations | \n'); } if (allow) { document.write('
3/11 - 8:24 AM \; \; | \n'); } if (allow) { document.write('Gilead Sciences Announces Expiration of Hart-Scott-Rodino Waiting Period for CymaBay Tender Offer | \n'); } if (allow) { document.write('
3/7 - 8:16 AM \; \; | \n'); } if (allow) { document.write('Gilead Sciences Aids in Reducing Cancer Care Disparities: Dale Shares Her Breast Cancer Journey and the Power of Information Sharing | \n'); } if (allow) { document.write('
3/6 - 4:30 PM \; \; | \n'); } if (allow) { document.write('Biktarvy Demonstrates High Rates of Viral Suppression in People With HIV and Comorbidities | \n'); } if (allow) { document.write('
3/6 - 10:25 AM \; \; | \n'); } if (allow) { document.write('Gilead and Merck Announce Phase 2 Data Showing an Investigational Oral Once-Weekly Combination Regimen of Islatravir and Lenacapavir Maintained Viral Suppression at Week 24 | \n'); } if (allow) { document.write('
3/6 - 8:00 AM \; \; | \n'); } if (allow) { document.write('Gilead and Merus Announce Collaboration to Discover Novel Antibody-Based Trispecific T-Cell Engagers | \n'); } if (allow) { document.write('
3/5 - 4:35 PM \; \; | \n'); } if (allow) { document.write('New Real-World Data Further Support the Use of Veklury (Remdesivir) for People Hospitalized With COVID-19 | \n'); } if (allow) { document.write('
3/5 - 4:30 PM \; \; | \n'); } if (allow) { document.write('Gilead\'s Innovative HIV Treatment Research Pipeline Aims to Address Unmet Needs and Advance Public Health | \n'); } if (allow) { document.write('
3/5 - 8:46 AM \; \; | \n'); } if (allow) { document.write('Gilead Sciences CEO on Company\'s Evolution and Commitment to the Bay Area | \n'); } if (allow) { document.write('
more news | \n'); } if (allow) { document.write('\n'); } if (allow) { document.write(' |